Robert B. Dickson
#133,450
Most Influential Person Now
Robert B. Dickson's AcademicInfluence.com Rankings
Robert B. Dicksonbiology Degrees
Biology
#8962
World Rank
#12109
Historical Rank
Cell Biology
#374
World Rank
#384
Historical Rank
Molecular Biology
#1175
World Rank
#1201
Historical Rank
Download Badge
Biology
Robert B. Dickson's Degrees
- PhD Molecular Biology Stanford University
- Masters Biochemistry University of California, San Francisco
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Robert B. Dickson Influential?
(Suggest an Edit or Addition)Robert B. Dickson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. (2006) (3085)
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells (1987) (1049)
- Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. (1987) (600)
- Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines (1992) (548)
- Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. (1988) (459)
- Growth factors in breast cancer. (1995) (409)
- Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine Protease* (2000) (392)
- Characterization of estrogen responsive transforming activity in human breast cancer cell lines. (1986) (364)
- Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. (1986) (340)
- Multicolour spectral karyotyping of mouse chromosomes (1996) (318)
- Induction of epidermal growth factor-related polypeptides by 17 beta-estradiol in MCF-7 human breast cancer cells. (1986) (314)
- Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. (1986) (305)
- C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance (2000) (292)
- Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. (1987) (278)
- Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. (1987) (256)
- Purification and Characterization of a Complex Containing Matriptase and a Kunitz-type Serine Protease Inhibitor from Human Milk* (1999) (250)
- Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. (2003) (243)
- Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer. (1998) (237)
- Molecular Cloning of cDNA for Matriptase, a Matrix-degrading Serine Protease with Trypsin-like Activity* (1999) (226)
- Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. (1987) (222)
- Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. (2002) (191)
- Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. (1989) (185)
- Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. (2001) (184)
- Morphologic characterization of the pathway of transferrin endocytosis and recycling in human KB cells. (1984) (182)
- Estrogen receptor-mediated processes in normal and cancer cells. (2000) (182)
- The Activation of Matriptase Requires Its Noncatalytic Domains, Serine Protease Domain, and Its Cognate Inhibitor* (2003) (178)
- Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. (1988) (175)
- Prometastatic Effect ofN-Acetylglucosaminyltransferase V Is Due to Modification and Stabilization of Active Matriptase by Adding β1–6 GlcNAc Branching* (2002) (173)
- Autocrine and paracrine growth regulation of human breast cancer. (1986) (169)
- Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin. (1982) (161)
- Characterization of Matriptase Expression in Normal Human Tissues (2003) (156)
- Roles of androgens in the development, growth, and carcinogenesis of the mammary gland (2002) (156)
- Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions. (1992) (156)
- Growth regulation of human breast carcinoma occurs through regulated growth factor secretion (1987) (152)
- The EGF receptor system as a target for antitumor therapy. (1991) (149)
- A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. (1988) (146)
- HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. (2005) (146)
- A Novel Biomarker for Staging Human Prostate Adenocarcinoma: Overexpression of Matriptase with Concomitant Loss of its Inhibitor, Hepatocyte Growth Factor Activator Inhibitor-1 (2006) (144)
- The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo. (1989) (141)
- Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. (2001) (138)
- Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. (1993) (137)
- The role of cathepsin D in the invasiveness of human breast cancer cells. (1993) (135)
- Characterization of a Novel, Membrane-bound, 80-kDa Matrix-degrading Protease from Human Breast Cancer Cells (1997) (135)
- Expression of the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Pathway in Normal Human Breast Epithelial Cells (1990) (135)
- Mechanisms of growth control in normal and malignant breast epithelium. (1989) (130)
- Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. (1991) (128)
- Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells. (1993) (128)
- Transforming Growth Factor α Production and Epidermal Growth Factor Receptor Expression in Normal and Oncogene Transformed Human Mammary Epithelial Cells (1989) (127)
- A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine. (1992) (126)
- Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. (1988) (124)
- Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines (1989) (120)
- Control of human breast cancer by estrogen, growth factors, and oncogenes. (1988) (116)
- Breast Cancer: Cellular and Molecular Biology (2011) (115)
- Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. (1993) (113)
- Production of and responsiveness to transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. (1989) (113)
- Roles of the matrix metalloproteinases in mammary gland development and cancer (1998) (112)
- ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. (1989) (109)
- Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells (2005) (101)
- Defining a role for c-Myc in breast tumorigenesis (1997) (100)
- Matriptase activates stromelysin (MMP‐3) and promotes tumor growth and angiogenesis (2006) (100)
- Prelysosomal divergence of transferrin and epidermal growth factor during receptor-mediated endocytosis. (1983) (97)
- alpha 2-macroglobulin adsorbed to colloidal gold: a new probe in the study of receptor-mediated endocytosis (1981) (97)
- Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability (1998) (96)
- Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids (1990) (96)
- Growth Factors, Apoptosis, and Survival of Mammary Epithelial Cells (1999) (92)
- Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. (1995) (92)
- Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice (2004) (92)
- Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. (1996) (90)
- The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. (1996) (90)
- Calmodulin-mediated Activation of Akt Regulates Survival of c-Myc-overexpressing Mouse Mammary Carcinoma Cells* (2004) (89)
- Type II transmembrane serine proteases (2003) (89)
- Deregulated activation of matriptase in breast cancer cells (2004) (88)
- Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. (1991) (88)
- Matrix metalloproteinase inhibitors (1997) (86)
- Sphingosine 1-Phosphate, Present in Serum-derived Lipoproteins, Activates Matriptase* (2002) (86)
- A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV‐cmyc transgenic mice (1999) (85)
- Binding and internalization of 125I-alpha 2-macroglobulin by cultured fibroblasts. (1981) (83)
- Regulatory Mechanisms in Breast Cancer (1991) (82)
- Inhibition of Tumor Invasion by Genomic Down-regulation of Matriptase through Suppression of Activation of Receptor-bound Pro-urokinase* (2004) (82)
- Growth regulatory peptide production by human breast carcinoma cells. (1988) (81)
- Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase. (2001) (81)
- Estrogen receptor in adult male rat liver. (1978) (81)
- The process of malignant progression in human breast cancer. (1990) (80)
- Indole‐3‐carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells (2006) (80)
- Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis (2008) (80)
- Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells. (2005) (80)
- Overexpression of c-Myc Alters G1/S Arrest following Ionizing Radiation (2002) (78)
- Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. (1995) (78)
- Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. (2007) (77)
- Receptor-mediated endocytosis in cultured fibroblasts: cryptic coated pits and the formation of receptosomes. (1981) (75)
- Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer (2004) (75)
- An unusual sex steroid-binding protein in mature male rat liver cytosol. (1978) (75)
- Additive effects of c‐erbB‐2, c‐Ha‐ras, and transforming growth factor‐α genes on in vitro transformation of human mammary epithelial cells (1992) (73)
- EGF receptor expression, regulation, and function in breast cancer (2004) (71)
- Mechanisms of normal and malignant breast epithelial growth regulation. (1989) (70)
- Role for Bcl-xLin the Regulation of Apoptosis by EGF and TGFβ1 in c-myc Overexpressing Mammary Epithelial Cells (1996) (70)
- Zymogen activation, inhibition, and ectodomain shedding of matriptase. (2008) (69)
- Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1. (2007) (69)
- Calmodulin modulates Akt activity in human breast cancer cell lines (2009) (67)
- Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. (1996) (67)
- Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia. (2005) (67)
- Oncogene-induced basement membrane invasiveness in human mammary epithelial cells (1994) (66)
- Of Mice and Myc: c-Myc and Mammary Tumorigenesis (2004) (65)
- Ultrastructure of the putative stem cell niche in rat mammary epithelium. (2003) (65)
- Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. (1999) (64)
- Growth factors in breast cancer: Mitogenesis to transformation (1992) (63)
- Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells. (1992) (63)
- Expression of amphiregulin, cripto-1, and heregulin-alpha in human breast-cancer cells. (1993) (62)
- The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. (1989) (62)
- Induction of Transforming Growth Factor β by the Antiestrogens Droloxifene, Tamoxifen, and Toremifene in MCF‐7 Cells (1991) (62)
- Detection of amphiregulin and Cripto‐1 in mammary tumors from transgenic mice (1996) (61)
- The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer. (1989) (61)
- Isolation and characterization of a highly enriched preparation of receptosomes (endosomes) from a human cell line. (1983) (60)
- Cell cycle basis for the onset and progression of c-Myc-induced, TGFα-enhanced mouse mammary gland carcinogenesis (2000) (58)
- Stromal influences on transformation of human mammary epithelial cells overexpressing c‐myc and SV40T (1990) (58)
- Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells. (2006) (57)
- Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors. (1998) (55)
- Molecular determinants of growth, angiogenesis, and metastases in breast cancer. (1992) (53)
- Detection of LOH and Mitochondrial DNA Alterations in Ductal Lavage and Nipple Aspirate Fluids from High-risk Patients (2004) (52)
- Microinjection of anticlathrin antibodies into fibroblasts does not interfere with the receptor-mediated endocytosis of α2-macroglobulin (1981) (52)
- Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin. (2003) (52)
- Growth control of normal and malignant breast epithelium. (1990) (48)
- Genes, oncogenes, and hormones : advances in cellular and molecular biology of breast cancer (1991) (47)
- Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models (2000) (47)
- Transferrin: Receptor-Mediated Endocytosis and Iron Delivery (1985) (46)
- Estrogen receptor in liver of male and female rats: endocrine regulation and molecular properties. (1979) (45)
- Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer. (2004) (45)
- Identification of membrane‐bound serine proteinase matriptase as processing enzyme of insulin‐like growth factor binding protein‐related protein‐1 (IGFBP‐rP1/angiomodulin/mac25) (2006) (45)
- Progestins and antiprogestins in mammary tumour growth and metastasis. (1994) (44)
- Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase. (2007) (44)
- Transforming Growth Factor-β Induces Platelet-Derived Growth Factor (PDGF) Messenger RNA and PDGF Secretion while Inhibiting Growth in Normal Human Mammary Epithelial Cells (1990) (44)
- Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. (1994) (42)
- c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells (2003) (41)
- Modulation by estrogen and growth factors of transforming growth factor-alpha and epidermal growth factor receptor expression in normal and malignant human mammary epithelial cells. (1989) (40)
- 17 Alpha-ethinyl estradiol is more potent than estradiol in receptor interactions with isolated hepatic parenchymal cells. (1981) (40)
- Role for Bcl-xL in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells. (1996) (40)
- Alterations in behavior, steroid hormones and natural killer cell activity in male transgenic TGFα mice (1992) (39)
- Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells. (2003) (39)
- Autocrine and paracrine growth regulation of human breast cancer (1986) (39)
- Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc (2001) (37)
- Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contacts. (2004) (36)
- Regulation of the expression of c-Myc by β1 integrins in epithelial cells (2001) (35)
- Hormones and growth factors in development and neoplasia Edited by Robert B. Dickson and David S. Salomon. Wiley-Liss Inc., New York, 1998, 461 pp. ISBN: 0-471-16899-8, £80.95 (1998) (35)
- Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study. (2009) (35)
- Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc. (1998) (34)
- Estrogens Regulate Production of Specific Growth Factors in Hormone‐Dependent Human Breast Cancer (1986) (34)
- Coexpression of β1,6-N-Acetylglucosaminyltransferase V Glycoprotein Substrates Defines Aggressive Breast Cancers with Poor Outcome (2005) (34)
- Expression and ligand binding of α2β1 integrin on breast carcinoma cells (1995) (33)
- Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines. (1989) (33)
- Transfected MCF-7 cells as a model for breast cancer progression (2004) (33)
- Cell Death in MMTV-c-myc Transgenic Mouse Mammary Tumors May Not Be Typical Apoptosis (2003) (32)
- Transgenic mouse models of breast cancer (2005) (32)
- Hormonal control of human breast cancer cell lines. (1986) (32)
- Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium. (2005) (32)
- Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells. (1990) (31)
- Stress influence on development of hepatocellular tumors in transgenic mice overexpressing TGF alpha. (1995) (31)
- Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin (2005) (30)
- Mammary Tumor Cell Cycle, Differentiation, and Metastasis (1996) (29)
- Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation. (2006) (28)
- Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice. (1997) (28)
- Matrix-degrading metalloproteinase (1994) (27)
- Molecular insights into breast cancer from transgenic mouse models (1991) (26)
- Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells. (1989) (26)
- The role of erbB-2 and its ligands in growth control of malignant breast epithelium (1992) (26)
- Binding and internalization of α2-macroglobulin by cultured fibroblasts: Effects of monovalent ionophores (1982) (26)
- Expression and ligand binding of alpha 2 beta 1 integrin on breast carcinoma cells. (1995) (26)
- Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation (2010) (26)
- Secreted and cellular polypeptide patterns of MCF-7 human breast cancer cells following either estrogen stimulation or v-H-ras transfection. (1989) (25)
- Internalization of alpha 2 macroglobulin in receptosomes. Studies with monovalent electron microscopic markers. (1981) (24)
- Female and male green monkey liver estrogen receptor. (1979) (24)
- Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis (2005) (24)
- Regulatory mechanisms in breast cancer. Advances in cellular and molecular biology of breast cancer. (2012) (23)
- Tyrosine kinase receptor--nuclear protooncogene interactions in breast cancer. (1992) (23)
- Purification and characterization of a novel growth factor from human breast cancer cells. (1992) (23)
- Characterization of a novel amphiregulin‐related molecule in 12‐O‐tetradecanoylphorbol‐13‐acetate‐treated breast cancer cells (1996) (22)
- Activation of Protein Kinase C by Phorbol Esters Modulates α2β1Integrin on MCF-7 Breast Cancer Cells (1999) (22)
- Estrogen receptors in the male. (1981) (22)
- Stimulatory and inhibitory growth factors and breast cancer (1990) (22)
- Breast cancer: influence of endocrine hormones, growth factors and genetic alterations. (1993) (21)
- Regulation of tumor-host interactions in breast cancer (1992) (21)
- Antiestrogen resistance in ER positive breast cancer cells (2004) (19)
- Reversible and irreversible inhibitors of clustering of alpha 2M in clathrin-coated pits on the surface of fibroblasts. (1982) (19)
- Estrogen receptor in rat liver: translocation to the nucleus in isolated parenchymal cells. (1979) (19)
- Characterization of mammary-derived growth factor 1 receptors and response in human mammary epithelial cell lines. (1990) (18)
- Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice (2004) (18)
- Endocrine therapy of human breast cancer cells: the role of secreted polypeptide growth factors. (1989) (18)
- Growth factor and sex steroid interactions in breast cancer (1996) (18)
- Stimulation of epithelial membrane antigen expression by transforming growth factor-beta in normal and oncogene-transformed human mammary epithelial cells. (1989) (18)
- Mammary Tumorigenesis and Malignant Progression (1994) (17)
- Mitogenic regulation of normal and malignant breast epithelium. (1989) (16)
- Inhibition by bacitracin of high affinity binding of 125I‐α2M to plasma membranes (1981) (16)
- Opposing behavioural alterations in male and female transgenic TGF alpha mice: association with tumour susceptibility. (1993) (16)
- RECEPTOR‐MEDIATED ENDOCYTOSIS OF α2‐MACROGLOBULIN: INHIBITION BY IONOPHORES AND STIMULATION BY Na+ AND HCO3‐ (1982) (15)
- Regulation of basement membrane invasiveness in human breast cance model systems (1991) (15)
- Potentiation of diethylstilbestrol‐induced alterations in the female mouse reproductive tract by transforming growth factor‐α transgene expression (1996) (15)
- Dual regulation of the epidermal growth factor family of growth factors in breast cancer by sex steroids and protein kinase C (1996) (15)
- Receptor-induced phosphorylation by mammary-derived growth factor 1 in mammary epithelial cell lines. (1992) (14)
- Tissue culture conditions determine the effects of estrogen and growth factors on the anchorage independent growth of human breast cancer cell lines (1991) (14)
- Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation. (2008) (14)
- Regulation of breast cancer cells by hormones and growth factors: effects on proliferation and basement membrane invasiveness. (1989) (13)
- Role of estrogens in the malignant progression of breast cancer: new perspectives (1986) (13)
- Receptor-bound estrogens and their metabolites in the nucleus of the isolated rat liver parenchymal cell. (1980) (13)
- A nuclear localization signal in steroid hormone receptors (1987) (12)
- Genes, Oncogenes, and Hormones (1992) (11)
- Understanding of the molecular basis of drug resistance in cancer reveals new targets for chemotherapy. (1990) (11)
- Are cellular adhesion molecules involved in the metastasis of breast cancer? (2004) (11)
- Synergistic Interaction of Transforming Growth Factor a and c-myc in Mouse Mammary and Salivary (1995) (11)
- Mechanisms of hormone and cytotoxic drug interactions in the development and treatment of breast cancer. (1990) (10)
- Microinjection of anticlathrin antibodies into cultured fibroblasts: clathrin-coated structures in receptor-mediated endocytosis and in exocytosis. (1982) (10)
- Early Parity Significantly Elevates Mammary Tumor Incidence in MMTV-c-myc Transgenic Mice (2003) (10)
- Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins (1993) (9)
- The role of growth factors in breast cancer (1988) (9)
- Angiogenesis inhibitorO-(chloroacetyl-carbamoyl) fumagillol (TNP-470) inhibits tumor angiogenesis, growth and spontaneous metastasis of MKL- 4 human breast cancer cells in female athymic nude mice (1994) (9)
- Production and characterization of mammary-derived growth factor 1 in mammary epithelial cell lines. (1992) (9)
- UCLA colloquium. New insights into breast cancer: the molecular biochemical and cellular biology of breast cancer. (1990) (8)
- Endocytosis of polypeptides and their receptors (1985) (8)
- The possible link between receptor phosphorylation and internalization (1985) (8)
- Chapter 8: Estrogen Receptor-Mediated Processes in Normal and Cancer Cells (2000) (8)
- Hormones and breast cancer in vitro. (1989) (8)
- Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat (2001) (8)
- The role of erbB-2 and its ligands in growth control of malignant breast epithelium. (1991) (7)
- The cellular response of human breast cancer to estrogen. (1988) (7)
- Involvement of Na+ and HCO 3− in receptor‐mediated endocytosis of α2‐macroglobulin, epidermal growth factor, and vesicular stomatitis virus (1982) (7)
- Transforming growth factor-beta induces platelet-derived growth factor (PDGF) messenger RNA and PDGF secretion while inhibiting growth in normal human mammary epithelial cells. (1990) (6)
- TGFβ Independently Regulates Invasiveness, Chemotaxis, and Proliferation of Human Breast Cancer Cells (1990) (6)
- Transition metal promoted alkylations of alkenols (1974) (6)
- A novel matrix-degrading protease in hormone-dependent breast cancer. (1994) (6)
- Activation of protein kinase C by phorbol esters modulates alpha2beta1 integrin on MCF-7 breast cancer cells. (1999) (6)
- Regulation of Cell‐Cycle Progression and Cell Death in Breast Cancer (1997) (6)
- Assay of mitogen-induced effects on cellular incorporation of precursors for scavenger, de novo, and net DNA synthesis. (1987) (5)
- Receptor-mediated Endocytosis in Cultured Cells: Coated Pits, Receptosomes, and Lysosomes (1981) (5)
- 8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer. (1986) (5)
- Fluorescence in situ hybridization assessment of c-myc gene amplification in breast tumor tissues. (2006) (4)
- Regulation of proliferation and differentiation of normal and malignant breast: new factors and neu paradoxes (1993) (4)
- Mechanisms of DES carcinogenicity: effects of the TGF alpha transgene. (1997) (4)
- Anti-invasion drugs (2005) (4)
- Phosphorylation of the estrogen receptor in MCF-7 human breast cancer cells (1987) (4)
- Receptor- and signal transductionrelated proto-oncogenes in breast cancer (1987) (4)
- In vivo/in vitro Selection of Hormone-Independent Cells from the Hormone-Dependent MCF-7 Human Breast Cancer Cell Line (1989) (4)
- Mammary tumorigenesis and malignant progression : advances in cellular and molecular biology of breast cancer (1994) (4)
- Blood-borne indicators of breast cancer and their use in experimental, medical oncologic, and prevention studies (1996) (4)
- New approaches in the therapy of breast cancer — introduction (2005) (3)
- EGF receptor in breast cancer chemoresistance. (2007) (3)
- Growth Factors as Local Regulators of Normal and Malignant Human Mammary Epithelium (1991) (3)
- Molecular aspects of breast cancer (1996) (3)
- Matrix-degrading proteases in hormone-dependent breast cancer (2004) (3)
- Transforming Growth Factor Alpha and its Receptor in Human Mammary Epithelial Cells: Modulation of Epidermal Growth Factor Receptor Function with Oncogenic Transformation (1989) (3)
- Mechanisms of estrogenic regulation of human breast cancer cells in long term tissue culture (1984) (2)
- Phorbol ester induced phosphorylation of the estrogen receptor in intact MCF-7 human breast cancer cells (1986) (2)
- Role of Integrins in the Development and Malignancy of the Breast (1999) (2)
- Detection of cyclin messenger RNAs by nonradioactive ribonuclease protection assay: a comparison of four detection methods. (1995) (2)
- Isolation of receptosomes (endosomes) from human KB cells. (1985) (2)
- Trends in Pharmacological sciences including Toxicological sciences (1989) (1)
- Estrogen-receptor negative human-breast cancer cell-lines are more invasive invitro and invivo than estrogen-receptor positive lines (1988) (1)
- c-Myc in Cellular Transformation and Cancer (2004) (1)
- Application of flow cytometry in the analysis and sterile sorting of cell populations based on integrin expression. (1999) (1)
- Inhibition by bacitracin of high affinity binding of 125I-alpha 2M to plasma membranes. (1981) (1)
- Binding and internalization of alpha 2-microglobulin by cultured fibroblasts. Effects of monovalent ionophores. (1982) (1)
- Transcription Factors (2004) (1)
- Production of transforming growth factors (TGF) by human breast cancer (BC) cell lines (1985) (1)
- Invasion-inhibiting factor 2-albumin conjugate inhibits invasion and spontaneous metastasis of MKL-4 human breast cancer cells transplanted into female nude mice (1996) (1)
- Regulation of invasiveness of human breast cancer cell lines in vitro. (1988) (1)
- The molecular biology of receptors: Techniques and application of receptor research: Edited by A. D. Strosberg, VCH and Ellis Horwood, 1987, £36.45/DM.105 (235 pages) ISBN 0 89573 558 X (1988) (1)
- Regulation of Growth and Secretion of Growth Factors by 17 B-Estradiol and V-RASH Oncogene in Human Mammary Carcinoma Cell Lines (1987) (1)
- Behavioral, Hormonal and Neurochemical Alterations in Transgenic Mice Overexpressing Transforming Growth Factorα (1993) (1)
- Molecular basis of steroid and growth factor receptors as prognostic variables in breast cancer (1991) (1)
- 676 – ESTROGEN RECEPTOR IN THE MAMMALIAN LIVER: IDENTIFICATION IN ADULT MALE RAT LIVER CYTOSOL AFTER SEPARATION FROM AN UNUSUAL SEX STEROID BINDING PROTEIN (1978) (1)
- Bicyclic Peptide Inhibitors of an Epithelial Cell-Derived Transmembrane Protease, Matriptase (2001) (1)
- In vitro nuclear translocation of the estrogen receptor in the hepatic parenchymal cell from male rats. (1980) (1)
- 10 – Organelles of Endocytosis and Exocytosis (1988) (1)
- Signaling Pathways in the Normal and Neoplastic Breast (2010) (0)
- Fibroblast Growth Factor 4 Transfection of MCF-7 Cells Produces Cell Lines That Are Tumorigenic and Metastatic in Ovariectomized or Tamoxifen-treated Athymic Nude Mice 1 (2006) (0)
- Characterization of Early Genomic Changes in Mammary Glands of High Risk Women (2000) (0)
- Obituary | The Journal of Steroid Biochemistry and Molecular Biology - Volume 104, Issues 3–5 (2007) (0)
- The Role of Angiogenesis in Breast Cancer Progression (2001) (0)
- The Roles of Transforming Growth Factors α and β in Growth Regulation of Normal and Transformed Human Mammary Epithelial Cells (1989) (0)
- A breast cancer Website (1999) (0)
- Mechanisms for c-Myc-Induced, TGF - Prevented Mouse Mammary Tumors (2003) (0)
- Modulation of Cyclin Expression by c-Myc in Malignant and Nonmalignant Mammary Epithelial Cells. (1995) (0)
- Fibroblast Growth Factor 4 Transfection of MCF-7 Cells Produces Cell Lines That Are Tumorigenic and Metastatic in Ovariectomized or Tamoxifen-treated Athymic Nude Mice1 (2006) (0)
- Growth factors, oncogenes and anti-oncogenes in cancer. (1989) (0)
- Estrogens regulate production of specific growth factors in hormone-dependent human breast cancer. (1987) (0)
- Book Review Molecular Basis of Breast Cancer: Prevention and Treatment By José Russo and Irma H. Russo. 448 pp., illustrated. Berlin, Springer-Verlag, 2004. $249. 3-540-00391-6 (2004) (0)
- A novel TGFβ- unrelated growth inhibitor in MCF-7 human breast cancer cells (1987) (0)
- TGFa-myc Interactions in Mammary Tumorigenesis. (1996) (0)
- Hormones and Breast Cancer Cells In Vitro(第134回北里医学会招待学術講演会要旨) (1990) (0)
- IN VITRO MODELS OF MALIGNANT PROGRESSION OF BREAST CANCER (1990) (0)
- Comprehensive Postdoctoral Training Program in Breast Cancer Biology (2002) (0)
- Detection of pregnancy-specific β1 glycoproteins in human milk (1996) (0)
- Metalloproteinase decomposant les matrices (1993) (0)
- Combined M.D./Ph.D. and Ph.D. Training Program in Breast Cancer Prevention (2002) (0)
- v-H-ras Oncogene transforms hormone dependent human breast cancer cell line into hormone independent tumorigenic cell line (1986) (0)
- The Role of Mammary Epithelial Stem Cells in the Transition from Normal to Malignant Epithelium (2001) (0)
- Hormones and Breast Cancer Cells In Vitro (1990) (0)
- Transfection ras vH-Breast Cancer Cells following either Estrogen Stimulation or Secreted and Cellular Polypeptide Patterns of MCF-7 Human Updated (2006) (0)
- Fas/FasL System in c-Myc Expressing Mammary Carcinoma Cells (2002) (0)
- Growth factors in normal and malignant mammary epithelial proliferation (1990) (0)
- MDGF1: a multifunctional growth factor in human milk and human breast cancer. (1994) (0)
- X^e^*' AD Award Number: DAMD17-99-1-9192 TITLE: A Novel Serine Protease Target for Prevention of Breast Cancer by a Soy Bean-Derived Inhibitor PRINCIPAL INVESTIGATOR: (0)
- A Comprehensive Postdoctoral Training Program in Breast Cancer (2003) (0)
- Growth regulation of cancer II : proceedings of a UCLA symposium, held at Keystone, Colorado, January 21-27, 1989 (1990) (0)
- A Novel Serine Protease Target for Prevention of Breast Cancer by a Soy Bean-Derived Inhibitor (2002) (0)
- THE ROLE OF THE RECEPTOSOME IN RECEPTOR-MEDIATED ENDOCYTOSIS (1981) (0)
- CHAPTER 345 – Signaling Pathways in the Normal and Neoplastic Breast (2003) (0)
- European Organization for Research and Treatment of Cancer Workshop Problems and Prospects in Current Therapeutic Application of Molecular Biology1 (1987) (0)
- MDGF-1: A New Tyrosine Kinase-Associated Growth Factor (1993) (0)
- OBITUARY (2007) (0)
- Acollectionofbreastcancercelllinesforthestudyoffunctionally distinct cancer subtypes (2006) (0)
- Production and localization of mammary-derived growth factor 1 in the normal and malignant mammary gland (1994) (0)
- Fibrosis without an Antitumor Effect in Nude Mice 1 Induces Cachexia and Systemic β Transforming Growth Factor (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert B. Dickson?
Robert B. Dickson is affiliated with the following schools:
